25 XP   0   0   10

Healius Ltd
Buy, Hold or Sell?

Let's analyse Healius together

PenkeI guess you are interested in Healius Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Healius Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Healius Ltd

I send you an email if I find something interesting about Healius Ltd.

Quick analysis of Healius (30 sec.)










What can you expect buying and holding a share of Healius? (30 sec.)

How much money do you get?

How much money do you get?
A$0.12
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$2.07
Expected worth in 1 year
A$-0.21
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-2.10
Return On Investment
-153.3%

For what price can you sell your share?

Current Price per Share
A$1.37
Expected price per share
A$1.1825 - A$1.695
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Healius (5 min.)




Live pricePrice per Share (EOD)

A$1.37

Intrinsic Value Per Share

A$0.73 - A$6.34

Total Value Per Share

A$2.80 - A$8.42

2. Growth of Healius (5 min.)




Is Healius growing?

Current yearPrevious yearGrowGrow %
How rich?$988.5m$1.2b-$272.6m-27.6%

How much money is Healius making?

Current yearPrevious yearGrowGrow %
Making money-$241.3m$202m-$443.4m-183.7%
Net Profit Margin-21.5%13.2%--

How much money comes from the company's main activities?

3. Financial Health of Healius (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#32 / 152

Most Revenue
#13 / 152

Most Profit
#149 / 152
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Healius? (5 min.)

Welcome investor! Healius's management wants to use your money to grow the business. In return you get a share of Healius.

What can you expect buying and holding a share of Healius?

First you should know what it really means to hold a share of Healius. And how you can make/lose money.

Speculation

The Price per Share of Healius is A$1.37. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Healius.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Healius, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$2.07. Based on the TTM, the Book Value Change Per Share is A$-0.57 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Healius.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.33-24.3%-0.33-24.3%0.2820.3%-0.01-0.4%-0.02-1.2%
Usd Book Value Change Per Share-0.38-27.4%-0.38-27.4%0.064.2%-0.06-4.1%-0.11-7.8%
Usd Dividend Per Share0.032.3%0.032.3%0.096.5%0.053.5%0.053.9%
Usd Total Gains Per Share-0.34-25.1%-0.34-25.1%0.1510.7%-0.01-0.7%-0.05-3.9%
Usd Price Per Share2.09-2.09-2.41-2.30-2.51-
Price to Earnings Ratio-6.28--6.28-8.65-17.51-78.77-
Price-to-Total Gains Ratio-6.06--6.06-16.41--38.70-24.96-
Price to Book Ratio1.53-1.53-1.39-1.39-1.36-
Price-to-Total Gains Ratio-6.06--6.06-16.41--38.70-24.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.899131
Number of shares1112
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.05
Usd Book Value Change Per Share-0.38-0.06
Usd Total Gains Per Share-0.34-0.01
Gains per Quarter (1112 shares)-383.06-10.15
Gains per Year (1112 shares)-1,532.25-40.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1138-1670-1542211-251-51
2276-3340-3074422-503-92
3414-5010-4606633-754-133
4552-6681-6138843-1006-174
5690-8351-76701054-1257-215
6827-10021-92021265-1509-256
7965-11691-107341476-1760-297
81103-13361-122661687-2012-338
91241-15031-137981898-2263-379
101379-16702-153302108-2514-420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%23.03.00.088.5%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%19.07.00.073.1%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%26.00.00.0100.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%21.05.00.080.8%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Healius

About Healius Ltd

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-02-05 02:50:10.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Healius Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Healius earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -21.5% means that $-0.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Healius Ltd:

  • The MRQ is -21.5%. The company is making a huge loss. -2
  • The TTM is -21.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-21.5%TTM-21.5%0.0%
TTM-21.5%YOY13.2%-34.7%
TTM-21.5%5Y-1.5%-20.1%
5Y-1.5%10Y-1.5%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.5%-11.2%-10.3%
TTM-21.5%-14.5%-7.0%
YOY13.2%-2.3%+15.5%
5Y-1.5%-8.3%+6.8%
10Y-1.5%-7.6%+6.1%
1.1.2. Return on Assets

Shows how efficient Healius is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • -10.1% Return on Assets means that Healius generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Healius Ltd:

  • The MRQ is -10.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.1%TTM-10.1%0.0%
TTM-10.1%YOY7.4%-17.5%
TTM-10.1%5Y-0.3%-9.8%
5Y-0.3%10Y-0.8%+0.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.1%-1.8%-8.3%
TTM-10.1%-2.4%-7.7%
YOY7.4%-1.5%+8.9%
5Y-0.3%-1.3%+1.0%
10Y-0.8%-1.7%+0.9%
1.1.3. Return on Equity

Shows how efficient Healius is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • -24.4% Return on Equity means Healius generated $-0.24 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Healius Ltd:

  • The MRQ is -24.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.4%TTM-24.4%0.0%
TTM-24.4%YOY16.0%-40.4%
TTM-24.4%5Y-1.4%-23.0%
5Y-1.4%10Y-2.0%+0.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.4%-0.3%-24.1%
TTM-24.4%-1.6%-22.8%
YOY16.0%-0.9%+16.9%
5Y-1.4%-2.6%+1.2%
10Y-2.0%-3.0%+1.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Healius Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Healius is operating .

  • Measures how much profit Healius makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • An Operating Margin of 2.0% means the company generated $0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Healius Ltd:

  • The MRQ is 2.0%. The company is operating less efficient.
  • The TTM is 2.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY18.5%-16.5%
TTM2.0%5Y8.4%-6.4%
5Y8.4%10Y5.2%+3.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%-27.5%+29.5%
TTM2.0%-0.6%+2.6%
YOY18.5%3.4%+15.1%
5Y8.4%-1.8%+10.2%
10Y5.2%-2.4%+7.6%
1.2.2. Operating Ratio

Measures how efficient Healius is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are $0.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Healius Ltd:

  • The MRQ is 0.943. The company is less efficient in keeping operating costs low.
  • The TTM is 0.943. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.943TTM0.9430.000
TTM0.943YOY0.791+0.151
TTM0.9435Y0.900+0.043
5Y0.90010Y0.899+0.001
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9431.321-0.378
TTM0.9431.314-0.371
YOY0.7911.245-0.454
5Y0.9001.222-0.322
10Y0.8991.212-0.313
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Healius Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Healius is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.55 means the company has $0.55 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Healius Ltd:

  • The MRQ is 0.547. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.547. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.547TTM0.5470.000
TTM0.547YOY0.580-0.033
TTM0.5475Y0.770-0.223
5Y0.77010Y0.775-0.005
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5472.415-1.868
TTM0.5472.276-1.729
YOY0.5802.635-2.055
5Y0.7702.810-2.040
10Y0.7752.851-2.076
1.3.2. Quick Ratio

Measures if Healius is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.44 means the company can pay off $0.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Healius Ltd:

  • The MRQ is 0.445. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.445. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.445TTM0.4450.000
TTM0.445YOY0.469-0.025
TTM0.4455Y0.460-0.015
5Y0.46010Y0.537-0.077
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4451.299-0.854
TTM0.4451.391-0.946
YOY0.4691.764-1.295
5Y0.4601.781-1.321
10Y0.5371.893-1.356
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Healius Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Healius assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Healius to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.59 means that Healius assets are financed with 58.8% credit (debt) and the remaining percentage (100% - 58.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Healius Ltd:

  • The MRQ is 0.588. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.588. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.588TTM0.5880.000
TTM0.588YOY0.535+0.052
TTM0.5885Y0.519+0.069
5Y0.51910Y0.446+0.073
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5880.405+0.183
TTM0.5880.432+0.156
YOY0.5350.385+0.150
5Y0.5190.450+0.069
10Y0.4460.455-0.009
1.4.2. Debt to Equity Ratio

Measures if Healius is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Healius to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 142.5% means that company has $1.43 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Healius Ltd:

  • The MRQ is 1.425. The company is able to pay all its debts with equity. +1
  • The TTM is 1.425. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.425TTM1.4250.000
TTM1.425YOY1.153+0.273
TTM1.4255Y1.122+0.304
5Y1.12210Y0.860+0.262
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4250.537+0.888
TTM1.4250.563+0.862
YOY1.1530.595+0.558
5Y1.1220.697+0.425
10Y0.8600.743+0.117
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Healius Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Healius generates.

  • Above 15 is considered overpriced but always compare Healius to the Diagnostics & Research industry mean.
  • A PE ratio of -6.28 means the investor is paying $-6.28 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Healius Ltd:

  • The EOD is -2.704. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.278. Based on the earnings, the company is expensive. -2
  • The TTM is -6.278. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.704MRQ-6.278+3.573
MRQ-6.278TTM-6.2780.000
TTM-6.278YOY8.654-14.932
TTM-6.2785Y17.509-23.786
5Y17.50910Y78.774-61.266
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-2.704-0.109-2.595
MRQ-6.278-0.341-5.937
TTM-6.278-0.303-5.975
YOY8.654-0.228+8.882
5Y17.509-0.347+17.856
10Y78.7742.977+75.797
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Healius Ltd:

  • The EOD is 3.867. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.977. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.977. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.867MRQ8.977-5.110
MRQ8.977TTM8.9770.000
TTM8.977YOY5.402+3.575
TTM8.9775Y21.536-12.559
5Y21.53610Y-43.204+64.740
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD3.867-0.732+4.599
MRQ8.977-1.060+10.037
TTM8.977-2.089+11.066
YOY5.402-4.385+9.787
5Y21.536-2.474+24.010
10Y-43.204-3.948-39.256
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Healius is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.53 means the investor is paying $1.53 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Healius Ltd:

  • The EOD is 0.660. Based on the equity, the company is cheap. +2
  • The MRQ is 1.533. Based on the equity, the company is underpriced. +1
  • The TTM is 1.533. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.660MRQ1.533-0.873
MRQ1.533TTM1.5330.000
TTM1.533YOY1.387+0.146
TTM1.5335Y1.389+0.144
5Y1.38910Y1.363+0.026
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.6601.802-1.142
MRQ1.5331.941-0.408
TTM1.5332.143-0.610
YOY1.3873.098-1.711
5Y1.3893.541-2.152
10Y1.3634.010-2.647
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Healius Ltd.

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Healius Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.572-0.5720%0.089-746%-0.086-85%-0.162-72%
Book Value Per Share--2.0742.0740%2.647-22%2.554-19%2.835-27%
Current Ratio--0.5470.5470%0.580-6%0.770-29%0.775-29%
Debt To Asset Ratio--0.5880.5880%0.535+10%0.519+13%0.446+32%
Debt To Equity Ratio--1.4251.4250%1.153+24%1.122+27%0.860+66%
Dividend Per Share--0.0470.0470%0.135-65%0.072-35%0.081-42%
Eps---0.507-0.5070%0.424-219%-0.009-98%-0.025-95%
Free Cash Flow Per Share--0.3540.3540%0.679-48%0.434-18%0.277+28%
Free Cash Flow To Equity Per Share---0.151-0.1510%0.436-135%-0.005-97%-0.021-86%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--6.343--------
Intrinsic Value_10Y_min--0.726--------
Intrinsic Value_1Y_max--0.576--------
Intrinsic Value_1Y_min--0.228--------
Intrinsic Value_3Y_max--1.776--------
Intrinsic Value_3Y_min--0.554--------
Intrinsic Value_5Y_max--3.031--------
Intrinsic Value_5Y_min--0.735--------
Market Cap994711800.960-132%2308893085.4402308893085.4400%2664665919.360-13%2548495198.080-9%2774302037.568-17%
Net Profit Margin---0.215-0.2150%0.132-263%-0.015-93%-0.015-93%
Operating Margin--0.0200.0200%0.185-89%0.084-76%0.052-62%
Operating Ratio--0.9430.9430%0.791+19%0.900+5%0.899+5%
Pb Ratio0.660-132%1.5331.5330%1.387+11%1.389+10%1.363+12%
Pe Ratio-2.704+57%-6.278-6.2780%8.654-173%17.509-136%78.774-108%
Price Per Share1.370-132%3.1803.1800%3.670-13%3.510-9%3.821-17%
Price To Free Cash Flow Ratio3.867-132%8.9778.9770%5.402+66%21.536-58%-43.204+581%
Price To Total Gains Ratio-2.610+57%-6.058-6.0580%16.408-137%-38.701+539%24.956-124%
Quick Ratio--0.4450.4450%0.469-5%0.460-3%0.537-17%
Return On Assets---0.101-0.1010%0.074-235%-0.003-97%-0.008-92%
Return On Equity---0.244-0.2440%0.160-252%-0.014-94%-0.020-92%
Total Gains Per Share---0.525-0.5250%0.224-335%-0.014-97%-0.081-85%
Usd Book Value--988519060.000988519060.0000%1261146080.000-22%1217016468.000-19%1350825602.830-27%
Usd Book Value Change Per Share---0.375-0.3750%0.058-746%-0.057-85%-0.106-72%
Usd Book Value Per Share--1.3611.3610%1.737-22%1.676-19%1.860-27%
Usd Dividend Per Share--0.0310.0310%0.089-65%0.047-35%0.053-42%
Usd Eps---0.332-0.3320%0.278-219%-0.006-98%-0.016-95%
Usd Free Cash Flow--168800360.000168800360.0000%323752790.000-48%207023272.000-18%131913149.760+28%
Usd Free Cash Flow Per Share--0.2320.2320%0.446-48%0.285-18%0.182+28%
Usd Free Cash Flow To Equity Per Share---0.099-0.0990%0.286-135%-0.003-97%-0.014-86%
Usd Market Cap652829354.970-132%1515326531.9741515326531.9740%1748820242.876-13%1672577398.500-9%1820774427.256-17%
Usd Price Per Share0.899-132%2.0872.0870%2.409-13%2.304-9%2.508-17%
Usd Profit---241387140.000-241387140.0000%202074770.000-219%-4042808.000-98%-11128813.470-95%
Usd Revenue--1120238470.0001120238470.0000%1533248060.000-27%1225036454.000-9%1147191398.400-2%
Usd Total Gains Per Share---0.344-0.3440%0.147-335%-0.009-97%-0.053-85%
 EOD+4 -4MRQTTM+0 -0YOY+2 -335Y+4 -3110Y+5 -30

4.2. Fundamental Score

Let's check the fundamental score of Healius Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.704
Price to Book Ratio (EOD)Between0-10.660
Net Profit Margin (MRQ)Greater than0-0.215
Operating Margin (MRQ)Greater than00.020
Quick Ratio (MRQ)Greater than10.445
Current Ratio (MRQ)Greater than10.547
Debt to Asset Ratio (MRQ)Less than10.588
Debt to Equity Ratio (MRQ)Less than11.425
Return on Equity (MRQ)Greater than0.15-0.244
Return on Assets (MRQ)Greater than0.05-0.101
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Healius Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.314
Ma 20Greater thanMa 501.404
Ma 50Greater thanMa 1001.453
Ma 100Greater thanMa 2001.651
OpenGreater thanClose1.365
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Income before Tax  83,200-36,80046,400121,400167,800249,100416,900-814,200-397,300
Net Income from Continuing Operations  55,90016,10072,000-5,70066,300227,700294,000-674,000-380,000



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets3,653,200
Total Liabilities2,147,000
Total Stockholder Equity1,506,200
 As reported
Total Liabilities 2,147,000
Total Stockholder Equity+ 1,506,200
Total Assets = 3,653,200

Assets

Total Assets3,653,200
Total Current Assets344,300
Long-term Assets3,308,900
Total Current Assets
Cash And Cash Equivalents 115,300
Net Receivables 164,600
Inventory 32,800
Other Current Assets 31,600
Total Current Assets  (as reported)344,300
Total Current Assets  (calculated)344,300
+/-0
Long-term Assets
Property Plant Equipment 1,243,300
Goodwill 1,897,500
Long Term Investments 7,100
Intangible Assets 73,100
Other Assets 87,900
Long-term Assets  (as reported)3,308,900
Long-term Assets  (calculated)3,308,900
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities629,600
Long-term Liabilities1,517,400
Total Stockholder Equity1,506,200
Total Current Liabilities
Short-term Debt 263,000
Accounts payable 218,000
Other Current Liabilities 900
Total Current Liabilities  (as reported)629,600
Total Current Liabilities  (calculated)481,900
+/- 147,700
Long-term Liabilities
Long term Debt Total 1,503,000
Other Liabilities 14,400
Long-term Liabilities  (as reported)1,517,400
Long-term Liabilities  (calculated)1,517,400
+/-0
Total Stockholder Equity
Common Stock2,421,000
Retained Earnings -923,300
Accumulated Other Comprehensive Income 8,500
Total Stockholder Equity (as reported)1,506,200
Total Stockholder Equity (calculated)1,506,200
+/-0
Other
Capital Stock2,421,000
Cash and Short Term Investments 115,300
Common Stock Shares Outstanding 569,800
Current Deferred Revenue147,700
Liabilities and Stockholders Equity 3,653,200
Net Debt 1,650,700
Net Invested Capital 2,068,300
Net Tangible Assets -464,400
Net Working Capital -285,300
Property Plant and Equipment Gross 1,590,400
Short Long Term Debt Total 1,766,000



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-30
> Total Assets 
40,266
85,908
162,246
220,775
283,354
292,331
302,387
447,901
544,424
606,502
4,798,310
3,778,527
3,696,253
3,825,654
3,861,947
3,993,638
4,118,723
3,945,491
3,624,600
3,114,100
3,126,300
3,350,800
4,566,500
3,782,200
4,136,800
3,653,200
3,653,2004,136,8003,782,2004,566,5003,350,8003,126,3003,114,1003,624,6003,945,4914,118,7233,993,6383,861,9473,825,6543,696,2533,778,5274,798,310606,502544,424447,901302,387292,331283,354220,775162,24685,90840,266
   > Total Current Assets 
4,687
8,684
23,855
54,070
66,407
22,113
19,513
31,246
30,892
36,784
1,467,489
411,809
206,561
226,362
201,027
216,739
204,583
309,919
250,300
266,500
252,700
346,500
1,319,800
330,900
371,800
344,300
344,300371,800330,9001,319,800346,500252,700266,500250,300309,919204,583216,739201,027226,362206,561411,8091,467,48936,78430,89231,24619,51322,11366,40754,07023,8558,6844,687
       Cash And Cash Equivalents 
2,909
343
2,218
18
45
40
747
923
739
780
7,784
223,397
25,812
43,252
10,432
38,246
27,460
49,969
82,300
95,500
84,000
119,700
137,500
70,100
81,300
115,300
115,30081,30070,100137,500119,70084,00095,50082,30049,96927,46038,24610,43243,25225,812223,3977,7847807399237474045182,2183432,909
       Short-term Investments 
0
0
0
0
0
0
0
0
0
135
115
6,933
1,500
798
4,574
0
0
3,186
0
0
0
0
0
0
0
0
000000003,186004,5747981,5006,933115135000000000
       Net Receivables 
1,778
8,341
11,765
17,696
16,033
19,808
16,330
22,080
23,381
30,960
141,004
156,798
149,727
156,701
158,645
152,480
149,861
132,855
114,900
120,400
131,600
151,200
176,100
184,100
219,700
164,600
164,600219,700184,100176,100151,200131,600120,400114,900132,855149,861152,480158,645156,701149,727156,798141,00430,96023,38122,08016,33019,80816,03317,69611,7658,3411,778
       Other Current Assets 
0
0
9,872
36,356
48,744
2,265
0
4,829
2,356
2,370
1,297,473
2,965
5,218
0
1,301
0
0
95,694
27,600
25,500
14,900
31,500
26,100
40,800
70,800
31,600
31,60070,80040,80026,10031,50014,90025,50027,60095,694001,30105,2182,9651,297,4732,3702,3564,82902,26548,74436,3569,87200
   > Long-term Assets 
35,580
77,224
138,391
166,705
216,947
270,218
282,874
416,655
513,532
569,718
3,330,821
3,366,718
3,489,692
3,599,292
3,660,920
3,776,899
3,914,140
3,635,572
3,374,300
2,847,600
2,873,600
3,004,300
3,246,700
3,451,300
3,765,000
3,308,900
3,308,9003,765,0003,451,3003,246,7003,004,3002,873,6002,847,6003,374,3003,635,5723,914,1403,776,8993,660,9203,599,2923,489,6923,366,7183,330,821569,718513,532416,655282,874270,218216,947166,705138,39177,22435,580
       Property Plant Equipment 
9,349
22,237
37,597
42,628
68,487
96,533
94,010
107,027
139,612
151,366
352,809
340,249
379,202
416,744
433,846
456,760
427,922
468,880
342,200
299,000
297,500
327,000
1,043,600
1,244,900
1,270,900
1,243,300
1,243,3001,270,9001,244,9001,043,600327,000297,500299,000342,200468,880427,922456,760433,846416,744379,202340,249352,809151,366139,612107,02794,01096,53368,48742,62837,59722,2379,349
       Goodwill 
26,200
54,947
100,760
123,495
148,048
172,415
178,465
305,639
326,914
372,255
2,836,728
2,892,701
2,999,778
3,081,598
3,138,713
3,213,162
3,310,511
2,832,087
2,772,200
2,315,500
2,348,700
2,482,500
2,040,200
2,042,300
2,344,300
1,897,500
1,897,5002,344,3002,042,3002,040,2002,482,5002,348,7002,315,5002,772,2002,832,0873,310,5113,213,1623,138,7133,081,5982,999,7782,892,7012,836,728372,255326,914305,639178,465172,415148,048123,495100,76054,94726,200
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,200
1,300
11,900
10,500
600
1,200
5,600
5,800
7,100
7,1005,8005,6001,20060010,50011,9001,30036,20000000000000000000
       Intangible Assets 
26,200
54,947
100,760
123,495
148,048
172,415
178,465
305,639
40,223
39,919
75,363
68,956
64,157
63,508
65,313
68,523
132,435
289,970
220,700
166,600
148,400
77,900
79,300
76,300
75,200
73,100
73,10075,20076,30079,30077,900148,400166,600220,700289,970132,43568,52365,31363,50864,15768,95675,36339,91940,223305,639178,465172,415148,048123,495100,76054,94726,200
       Other Assets 
0
0
34
0
0
1,059
988
3,823
3,259
3,738
65,226
68,041
54,864
55,138
50,412
53,411
75,428
14,500
33,500
54,600
119,600
118,200
82,400
82,200
74,600
87,900
87,90074,60082,20082,400118,200119,60054,60033,50014,50075,42853,41150,41255,13854,86468,04165,2263,7383,2593,8239881,059003400
> Total Liabilities 
14,758
38,899
51,993
109,442
110,815
106,044
103,833
127,888
152,009
197,096
3,037,165
1,661,823
1,226,016
1,321,265
1,288,834
1,311,541
1,371,166
1,498,107
1,196,900
1,245,000
1,307,400
1,295,400
2,635,200
1,924,900
2,215,200
2,147,000
2,147,0002,215,2001,924,9002,635,2001,295,4001,307,4001,245,0001,196,9001,498,1071,371,1661,311,5411,288,8341,321,2651,226,0161,661,8233,037,165197,096152,009127,888103,833106,044110,815109,44251,99338,89914,758
   > Total Current Liabilities 
4,187
18,850
19,249
31,172
18,158
16,464
14,045
44,392
36,161
36,441
2,973,386
1,615,889
174,761
177,978
196,219
222,124
254,216
424,325
280,800
331,600
374,900
391,900
972,800
684,700
641,300
629,600
629,600641,300684,700972,800391,900374,900331,600280,800424,325254,216222,124196,219177,978174,7611,615,8892,973,38636,44136,16144,39214,04516,46418,15831,17219,24918,8504,187
       Short-term Debt 
0
0
0
0
0
5,261
4,448
5,482
9,628
6,240
2,196,419
1,432,261
4,142
3,754
3,804
3,781
3,072
167,277
2,000
300
800
600
183,400
230,000
223,700
263,000
263,000223,700230,000183,4006008003002,000167,2773,0723,7813,8043,7544,1421,432,2612,196,4196,2409,6285,4824,4485,26100000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
167,000
1,900
800
500
6,900
9,500
5,600
0
0
005,6009,5006,9005008001,900167,00000000000000000000
       Accounts payable 
0
0
3,983
3,940
4,248
5,382
5,790
13,199
11,234
13,616
93,727
106,517
88,234
78,825
91,040
98,575
103,296
139,000
156,500
203,300
217,300
222,900
202,300
205,900
169,600
218,000
218,000169,600205,900202,300222,900217,300203,300156,500139,000103,29698,57591,04078,82588,234106,51793,72713,61611,23413,1995,7905,3824,2483,9403,98300
       Other Current Liabilities 
3,057
15,141
15,266
27,232
13,910
5,821
3,807
12,610
9,449
11,058
671,289
66,856
67,961
85,449
101,375
90,333
147,848
122,462
122,300
128,000
156,800
6,900
447,900
52,300
5,700
900
9005,70052,300447,9006,900156,800128,000122,300122,462147,84890,333101,37585,44967,96166,856671,28911,0589,44912,6103,8075,82113,91027,23215,26615,1413,057
   > Long-term Liabilities 
10,571
20,049
32,744
78,270
92,657
89,580
89,788
83,496
115,848
160,655
63,779
45,934
1,051,255
1,143,287
1,092,615
1,089,417
1,116,950
1,073,782
916,100
913,400
932,500
903,500
1,662,400
1,240,200
1,573,900
1,517,400
1,517,4001,573,9001,240,2001,662,400903,500932,500913,400916,1001,073,7821,116,9501,089,4171,092,6151,143,2871,051,25545,93463,779160,655115,84883,49689,78889,58092,65778,27032,74420,04910,571
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,050,000
896,300
879,400
860,000
797,300
1,574,000
1,211,300
1,555,300
1,503,000
1,503,0001,555,3001,211,3001,574,000797,300860,000879,400896,3001,050,00000000000000000000
       Other Liabilities 
0
0
772
1,316
1,303
947
898
2,307
2,553
2,030
60,468
43,620
50,582
29,456
20,787
13,930
22,397
16,700
19,000
34,000
69,900
96,500
74,200
22,500
18,600
14,400
14,40018,60022,50074,20096,50069,90034,00019,00016,70022,39713,93020,78729,45650,58243,62060,4682,0302,5532,3078989471,3031,31677200
> Total Stockholder Equity
25,508
47,009
110,253
111,333
172,539
186,287
198,554
320,013
392,415
408,984
1,757,166
2,113,112
2,465,815
2,499,389
2,567,786
2,677,105
2,745,779
2,445,606
2,426,100
1,867,600
1,818,900
2,055,400
1,931,300
1,857,300
1,921,600
1,506,200
1,506,2001,921,6001,857,3001,931,3002,055,4001,818,9001,867,6002,426,1002,445,6062,745,7792,677,1052,567,7862,499,3892,465,8152,113,1121,757,166408,984392,415320,013198,554186,287172,539111,333110,25347,00925,508
   Common Stock
10,706
46,046
109,314
110,084
171,530
175,596
181,444
292,449
300,369
310,834
1,705,351
1,995,264
2,318,578
2,337,758
2,349,364
2,358,183
2,366,276
2,407,309
2,422,800
2,422,800
2,424,200
2,671,100
2,672,300
2,572,000
2,422,900
2,421,000
2,421,0002,422,9002,572,0002,672,3002,671,1002,424,2002,422,8002,422,8002,407,3092,366,2762,358,1832,349,3642,337,7582,318,5781,995,2641,705,351310,834300,369292,449181,444175,596171,530110,084109,31446,04610,706
   Retained Earnings 
479
963
939
1,249
1,009
10,691
17,110
27,564
87,272
93,402
44,241
109,087
138,867
154,251
221,951
309,659
371,530
44,198
8,500
-565,700
-618,200
-608,100
-737,600
-731,600
-521,200
-923,300
-923,300-521,200-731,600-737,600-608,100-618,200-565,7008,50044,198371,530309,659221,951154,251138,867109,08744,24193,40287,27227,56417,11010,6911,0091,249939963479
   Accumulated Other Comprehensive Income 
-3,670
-5,965
-10,375
-12,172
-19,984
-28,337
-38,833
-47,355
4,774
4,748
7,574
8,761
8,370
7,380
-3,529
9,263
7,973
-5,901
-5,200
10,500
12,900
-7,600
-3,400
16,900
19,900
8,500
8,50019,90016,900-3,400-7,60012,90010,500-5,200-5,9017,9739,263-3,5297,3808,3708,7617,5744,7484,774-47,355-38,833-28,337-19,984-12,172-10,375-5,965-3,670
   Capital Surplus 00000000000000000000000000
   Treasury Stock00-3,60000000000000000000000000
   Other Stockholders Equity 
17,993
5,965
10,375
12,172
19,984
0
0
0
0
0
0
0
0
0
0
0
0
-12,500
-7,300
10,500
12,900
-7,600
-1,934,700
-1,844,000
-1,901,700
-1,497,700
-1,497,700-1,901,700-1,844,000-1,934,700-7,60012,90010,500-7,300-12,50000000000000019,98412,17210,3755,96517,993



Balance Sheet

Currency in AUD. All numbers in thousands.